Skip to main content
Radcliffe Medical Education
Medical education learning resources for healthcare professionals
Radcliffe Medical Education banner
Radcliffe Medical Education banner
  • Home
  •  Transcatheter Interventions Online - Recent Trials & Future Technologies: Technologies and Controversies

Transcatheter Interventions Online - Recent Trials & Future Technologies: Technologies and Controversies

Topic:
  • Intervention
  • MI/ACS
  • Structural Heart Disease

Available Credit:

  • 1.00 EBAC

Course Published On:

Course Expiry Date:

TIO 2020 – Technologies and Controversies

Overview

In this session, 'Transcatheter Interventions Online 2020 - Recent Trials & Future Technologies: Technologies and Controversies' a leading faculty presents and discuss the latest in MCS in HRPCI, embolic protection in TAVI and non-hyperaemic angio-, OCT-, and MSCT-derived coronary physiology.

 

Transcatheter Interventions Online 2020 aims to educate interventionalists and allied healthcare professionals on the practical implications of the latest clinical data, device selection, and procedural strategies impacting optimum patient care. To further illustrate this, the event will feature a number of practical demonstrations in the form of live cases broadcast from cardiovascular centers of excellence globally, interspersed with presentations and debate sessions.

Support Statement

This programme is supported by unrestricted educational grants from the following companies. The scientific programme has not been influenced in any way by the sponsors.

  • Abbott
  • Abiomed
  • Boston Scientific
  • Edwards Lifesciences
  • Medtronic
  • Siemens Healthineers

Disclosure

In compliance with EBAC / EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.

 

The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

Terms & Conditions

Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.

 

This session ‘Transcatheter Interventions Online - Recent Trials & Future Technologies: Technologies and Controversies’ is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credits.

 

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

 

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

Instructions to Participants

There is no fee for taking part in this online learning activity.

 

Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

 

To complete the course and claim certification participants must:

  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

Target Audience

  • Cardiologists
  • Interventionalists
  • Surgeons who are involved and/or interested in transcatheter treatment strategies for coronary and structural heart disease

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
  • Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
  • Assess the merits of adopting emerging technologies within their practice
  • Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
  • Interact with opinion leaders in their profession

Module

Title

Duration

Speakers

1 MCS in HRPCI – Changing perspectives Holger Thiele (Heart Center Leipzig, Germany)
2 Embolic protection in TAVI David Hildick-Smith (Brighton and Sussex University Hospitals, Brighton, UK)
3 Non-hyperemic angio, OCT- MSCT derived coronary physiology Joost Daemen (Erasmus Medical Center, The Netherlands)
1.

MCS in HRPCI – Changing perspectives

Duration:

Speakers: Holger Thiele (Heart Center Leipzig, Germany)

3.

Non-hyperemic angio, OCT- MSCT derived coronary physiology

Duration:

Speakers: Joost Daemen (Erasmus Medical Center, The Netherlands)

Chair

Nicolas M Van Mieghem

Erasmus University Medical Center, Rotterdam, NL

Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor.

View full profile

Ajay J Kirtane

New York-Presbyterian Hospital, New York City, US

Ajay J Kirtane, is Professor of Medicine at the Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUMC. Dr.

View full profile

Panelist

Holger Thiele

Leipzig Heart Center, Leipzig, DE

Dr Holger Thiele, former director and full professor in the Department of Internal Medicine/Cardiology/Angiology of the University Heart Center Lübeck at the University of Lübeck has been nominated by the faculty of the University of Leipzig as full Professor and Director of the Department of Int

View full profile

Joost Daemen

Thoraxcenter, Erasmus University Medical Center, Rotterdam, NL

Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL.

View full profile

David Hildick-Smith

Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, UK

Prof David Hildick-Smith is Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre - the Regional Specialist Unit.

View full profile

Roxana Mehran

Mount Sinai Hospital, New York City, US

Roxana Mehran is an internationally recognised interventional cardiologist and clinical researcher based in New York, United States.

View full profile
1.00 EBAC

Related Courses

Advancing Tricuspid Valve Replacement
  • 1.00 ACCME

Learning objectives

  • List clinical trial data and real-world evidence for TTVR
  • Recall guideline recommendations for TTVR
  • Select appropriate patients for TTVR based on the heart-team and patient choice
  • Use expert guidance to develop an evidence-based approach to managing TR with TTVR
See more
TAVI Index Procedure: The Value of Valve Optimisation on Long-term Outcomes and Lifetime Management
  • 1.00 EBAC

Learning objectives

  • Recall the critical steps in lesion preparation and on post dilation to optimise valve implantation when needed
  • Recognise the technical considerations in precise valve positioning and deployment for larger annuli patients
  • Explore the long-term implications of index procedure optimisation on patient management and outcomes
  • Engage with an expert operator through a live case demonstration and interactive discussion
See more